343 related articles for article (PubMed ID: 29474312)
21. Optimization of Medication Use at Accountable Care Organizations.
Wilks C; Krisle E; Westrich K; Lunner K; Muhlestein D; Dubois R
J Manag Care Spec Pharm; 2017 Oct; 23(10):1054-1064. PubMed ID: 28944730
[TBL] [Abstract][Full Text] [Related]
22. Why Do Accountable Care Organizations Leave The Medicare Shared Savings Program?
Bleser WK; Saunders RS; Muhlestein DB; McClellan M
Health Aff (Millwood); 2019 May; 38(5):794-803. PubMed ID: 31059355
[TBL] [Abstract][Full Text] [Related]
23. Financial Performance of Rural Medicare ACOs.
Nattinger MC; Mueller K; Ullrich F; Zhu X
J Rural Health; 2018 Dec; 34(1):98-102. PubMed ID: 27557414
[TBL] [Abstract][Full Text] [Related]
24. Association between specialist compensation and Accountable Care Organization performance.
Ganguli I; Lupo C; Mainor AJ; Orav EJ; Blanchfield BB; Lewis VA; Colla CH
Health Serv Res; 2020 Oct; 55(5):722-728. PubMed ID: 32715464
[TBL] [Abstract][Full Text] [Related]
25. Early Impact of Medicare Accountable Care Organizations on Inpatient Surgical Spending.
Nathan H; Thumma JR; Ryan AM; Dimick JB
Ann Surg; 2019 Feb; 269(2):191-196. PubMed ID: 29771724
[TBL] [Abstract][Full Text] [Related]
26. The Hidden Roles That Management Partners Play In Accountable Care Organizations.
Lewis VA; D'Aunno T; Murray GF; Shortell SM; Colla CH
Health Aff (Millwood); 2018 Feb; 37(2):292-298. PubMed ID: 29401012
[TBL] [Abstract][Full Text] [Related]
27. Distribution of Visits for Chronic Conditions Between Primary Care and Specialist Providers in Medicare Shared Savings Accountable Care Organizations.
Cole ES; Leighton C; Zhang Y
Med Care; 2018 May; 56(5):424-429. PubMed ID: 29634633
[TBL] [Abstract][Full Text] [Related]
28. Medicare Accountable Care Organizations: program eligibility, beneficiary assignment, and quality measures.
MacKinney AC; Mueller KJ; Zhu X; Vaughn T; ;
Rural Policy Brief; 2014 Apr; (2014 3):1-6. PubMed ID: 25399468
[TBL] [Abstract][Full Text] [Related]
29. Spending Among Patients With Cancer in the First 2 Years of Accountable Care Organization Participation.
Lam MB; Figueroa JF; Zheng J; Orav EJ; Jha AK
J Clin Oncol; 2018 Oct; 36(29):2955-2960. PubMed ID: 30156985
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of Rural Accountable Care Organizations (ACOs) – A Survey of Medicare ACOs with Rural Presence.
Salako A; Zhu X; MacKinney AC; Ullrich F; Mueller K; ;
Rural Policy Brief; 2015 May; (2015 8):1-4. PubMed ID: 26793816
[TBL] [Abstract][Full Text] [Related]
31. Changes in healthcare delivery following spinal fracture in Medicare Accountable Care Organizations.
Lipa SA; Blucher JA; Sturgeon DJ; Harris MB; Schoenfeld AJ
Spine J; 2019 Aug; 19(8):1340-1345. PubMed ID: 31009769
[TBL] [Abstract][Full Text] [Related]
32. Accountable Care Organizations in the United States: market and demographic factors associated with formation.
Lewis VA; Colla CH; Carluzzo KL; Kler SE; Fisher ES
Health Serv Res; 2013 Dec; 48(6 Pt 1):1840-58. PubMed ID: 24117222
[TBL] [Abstract][Full Text] [Related]
33. Spending outcomes among patients with cancer in accountable care organizations 4 years after implementation.
Erfani P; Phelan J; Orav EJ; Figueroa JF; Jha AK; Lam MB
Cancer; 2022 Mar; 128(5):1093-1100. PubMed ID: 34767638
[TBL] [Abstract][Full Text] [Related]
34. Physician Participation in Medicare Accountable Care Organizations and Spillovers in Commercial Spending.
Post B; Ryan AM; Moloci NM; Li J; Dupree JM; Hollingsworth JM
Med Care; 2019 Apr; 57(4):305-311. PubMed ID: 30789539
[TBL] [Abstract][Full Text] [Related]
35. Association Between Medicare Accountable Care Organization Implementation and Spending Among Clinically Vulnerable Beneficiaries.
Colla CH; Lewis VA; Kao LS; O'Malley AJ; Chang CH; Fisher ES
JAMA Intern Med; 2016 Aug; 176(8):1167-75. PubMed ID: 27322485
[TBL] [Abstract][Full Text] [Related]
36. Performance differences in year 1 of pioneer accountable care organizations.
McWilliams JM; Chernew ME; Landon BE; Schwartz AL
N Engl J Med; 2015 May; 372(20):1927-36. PubMed ID: 25875195
[TBL] [Abstract][Full Text] [Related]
37. VALUE AND PERFORMANCE OF ACCOUNTABLE CARE ORGANIZATIONS: A COST-MINIMIZATION ANALYSIS.
Parasrampuria S; Oakes AH; Wu SS; Parikh MA; Padula WV
Int J Technol Assess Health Care; 2018 Jan; 34(4):388-392. PubMed ID: 29991357
[TBL] [Abstract][Full Text] [Related]
38. Early Accountable Care Organization Results in End-of-Life Spending Among Cancer Patients.
Lam MB; Zheng J; Orav EJ; Jha AK
J Natl Cancer Inst; 2019 Dec; 111(12):1307-1313. PubMed ID: 30859226
[TBL] [Abstract][Full Text] [Related]
39. Recommended Cancer Screening in Accountable Care Organizations: Trends in Colonoscopy and Mammography in the Medicare Shared Savings Program.
Cole AP; Krasnova A; Ramaswamy A; Fletcher SA; Friedlander DF; McNabb-Baltar J; Melnitchouk N; Lipsitz SR; Sun M; Kibel AS; Golshan M; Haider AH; Weissman JS; Trinh QD
J Oncol Pract; 2019 Jun; 15(6):e547-e559. PubMed ID: 30998420
[TBL] [Abstract][Full Text] [Related]
40. Medicare Accountable Care Organizations and Use of Potentially Low-Value Procedures.
Modi PK; Kaufman SR; Borza T; Oliphant BW; Ryan AM; Miller DC; Shahinian VB; Ellimoottil C; Hollenbeck BK
Surg Innov; 2019 Apr; 26(2):227-233. PubMed ID: 30497340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
